Viewpoint

Interpreting Bayesian Trials—Rigor and Avoiding Misconception

JAMA Pediatrics 10.1001/jamapediatrics.2026.3557

August 17, 2026 at 11:00 AM EDT

Read the full article

This Viewpoint highlights several considerations important for stakeholders and reviewers to understand regarding the design, evaluation, and interpretation of trials using bayesian analyses.

Corresponding Author: John M. VanBuren, PhD, Department of Medicine, Rutgers University, 57 US Hwy 1, New Brunswick, NJ 08901 (john.vanburen@rutgers.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

https://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2026.3557?utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_term=081726

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks